These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15615113)

  • 41. The sclerostin story: from human genetics to the development of novel anabolic treatment for osteoporosis.
    Yavropoulou MP; Xygonakis C; Lolou M; Karadimou F; Yovos JG
    Hormones (Athens); 2014; 13(4):323-37. PubMed ID: 25555179
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of BMPs in the regulation of sclerostin as revealed by an epigenetic modifier of human bone cells.
    Delgado-Calle J; Arozamena J; Pérez-López J; Bolado-Carrancio A; Sañudo C; Agudo G; de la Vega R; Alonso MA; Rodríguez-Rey JC; Riancho JA
    Mol Cell Endocrinol; 2013 Apr; 369(1-2):27-34. PubMed ID: 23415712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BMP antagonists: their roles in development and involvement in pathophysiology.
    Yanagita M
    Cytokine Growth Factor Rev; 2005 Jun; 16(3):309-17. PubMed ID: 15951218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role and mechanism of action of sclerostin in bone.
    Delgado-Calle J; Sato AY; Bellido T
    Bone; 2017 Mar; 96():29-37. PubMed ID: 27742498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Novel Mutation in a Gene Causes Sclerosteosis in a Family of Mediterranean Origin.
    Ekhzaimy AA; Alyusuf EY; Alswailem M; Alzahrani AS
    Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208525
    [No Abstract]   [Full Text] [Related]  

  • 46. BMP and BMP inhibitors in bone.
    Rosen V
    Ann N Y Acad Sci; 2006 Apr; 1068():19-25. PubMed ID: 16831902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The -9247 T/C polymorphism in the SOST upstream regulatory region that potentially affects C/EBPalpha and FOXA1 binding is associated with osteoporosis.
    Huang QY; Li GH; Kung AW
    Bone; 2009 Aug; 45(2):289-94. PubMed ID: 19371798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone.
    Fijalkowski I; Geets E; Steenackers E; Van Hoof V; Ramos FJ; Mortier G; Fortuna AM; Van Hul W; Boudin E
    J Bone Miner Res; 2016 Apr; 31(4):874-81. PubMed ID: 26751728
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel SOST gene mutation in a sclerosteosis patient and her parents.
    Bhadada SK; Rastogi A; Steenackers E; Boudin E; Arya A; Dhiman V; Bhansali A; Van Hul W
    Bone; 2013 Feb; 52(2):707-10. PubMed ID: 23079137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cbfa1/RUNX2 directs specific expression of the sclerosteosis gene (SOST).
    Sevetson B; Taylor S; Pan Y
    J Biol Chem; 2004 Apr; 279(14):13849-58. PubMed ID: 14739291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Computational and functional characterization of four SNPs in the SOST locus associated with osteoporosis.
    Ye W; Wang Y; Mei B; Hou S; Liu X; Wu G; Qin L; Zhao K; Huang Q
    Bone; 2018 Mar; 108():132-144. PubMed ID: 29307778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Jun activation domain-binding protein 1 binds Smad5 and inhibits bone morphogenetic protein signaling.
    Haag J; Aigner T
    Arthritis Rheum; 2006 Dec; 54(12):3878-84. PubMed ID: 17133595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human genetics of SOST.
    Balemans W; Van Hul W
    J Musculoskelet Neuronal Interact; 2006; 6(4):355-6. PubMed ID: 17185822
    [No Abstract]   [Full Text] [Related]  

  • 54. Methylation of bone
    Shan Y; Wang L; Li G; Shen G; Zhang P; Xu Y
    Biochem Cell Biol; 2019 Aug; 97(4):369-374. PubMed ID: 30257098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rat Osteosarcoma Cells as a Therapeutic Target Model for Osteoregeneration via Sclerostin Knockdown.
    Sedaghati B; Jahroomishirazi R; Starke A; Hacker MC; Schulz-Siegmund M
    Cells Tissues Organs; 2016; 201(5):366-79. PubMed ID: 27233518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeted deletion of Sost distal enhancer increases bone formation and bone mass.
    Collette NM; Genetos DC; Economides AN; Xie L; Shahnazari M; Yao W; Lane NE; Harland RM; Loots GG
    Proc Natl Acad Sci U S A; 2012 Aug; 109(35):14092-7. PubMed ID: 22886088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction.
    Sobajima S; Shimer AL; Chadderdon RC; Kompel JF; Kim JS; Gilbertson LG; Kang JD
    Spine J; 2005; 5(1):14-23. PubMed ID: 15653081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sclerostin deficiency in humans.
    van Lierop AH; Appelman-Dijkstra NM; Papapoulos SE
    Bone; 2017 Mar; 96():51-62. PubMed ID: 27742500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heritable sclerosing bone disorders: presentation and new molecular mechanisms.
    de Vernejoul MC; Kornak U
    Ann N Y Acad Sci; 2010 Mar; 1192():269-77. PubMed ID: 20392246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity.
    Kusu N; Laurikkala J; Imanishi M; Usui H; Konishi M; Miyake A; Thesleff I; Itoh N
    J Biol Chem; 2003 Jun; 278(26):24113-7. PubMed ID: 12702725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.